Back
Open Access

Inhibition of SRSF4 in cardiomyocytes induces left ventricular hypertrophy

Session: Poster session 1 - Cardiomyopathies and fibrosis
Topic: Cardiomyopathies
Speaker: Mr J. Larrasa-Alonso (Madrid, ES)
Event: Frontiers in CardioVascular Biology 2016

Congress Presentation

Add to my library

Like

About the speaker

Mr Javier Larrasa-Alonso

National Centre for Cardiovascular Research (CNIC), Madrid (Spain)
0 follower

12 more presentations in this session

Cardiomyopathies and fibrosis - Poster discussant:

Access
Like
Thumbnail

Plakophilin-2 haploinsufficiency leads to impaired canonical Wnt signaling in ARVC patient

Speaker: Doctor A. Khudiakov (Saint Petersburg, RU)

Access
Abstract
Like
Thumbnail

Improved technique for customized, easier, safer and more reliable transverse aortic arch banding and debanding in mice as a model of pressure overload hypertrophy

Speaker: Doctor J. Nistal (Santander, ES)

Access
Abstract
Like
Thumbnail

Late sodium current inhibitors for the treatment of inducible obstruction and diastolic dysfunction in hypertrophic cardiomyopathy: a study on human myocardium.

Speaker: Doctor C. Ferrantini (Florence, IT)

Access
Abstract
Like
Thumbnail

Angiotensin II receptor antagonist fimasartan has protective role of left ventricular fibrosis and remodeling in the rat ischemic heart

Speaker: Professor S. Park (Seoul, KR)

Access
Abstract
Like
Thumbnail

Access the full session

Poster session 1 - Cardiomyopathies and fibrosis

Speakers: Mr J. Larrasa-Alonso, Doctor A. Khudiakov, Doctor J. Nistal, Doctor C. Ferrantini, Professor S. Park
Access
Like
Thumbnail

About the event

Image

Frontiers in CardioVascular Biology 2016

8 July - 10 July 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources